Radiation Therapy

Focused ultrasound could provide clinicians a safer alternative in diagnosing, monitoring and treating patients with brain tumors compared with biopsy, according to findings published in npj Precision Oncology.

Compared with expectant management, imaging-based surveillance did not improve outcomes among patients in remission after completion of primary radiation therapy for head and neck cancer, according to data published in JAMA Network Open.

A phase 2 trial conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated the safety and potential efficacy of neoadjuvant immunotherapy for patients with soft tissue sarcoma.

Adverse events experienced by men with prostate cancer varied considerably based on the treatment they received, results of a 10-year follow-up study showed.

Most oncologists treating non-small cell lung cancer reported more research into immunotherapy treatments, patients with comorbidities and biomarker testing will be vital to improving care, according to results of a nationwide survey.

MIAMI BEACH, Fla. — Patients who are elderly or are poor candidates for surgery with nonmelanoma skin cancer would benefit from superficial radiation therapy, according to a speaker at South Beach Symposium.

Researchers at Sylvester Comprehensive Cancer Center at University of Miami devised an MRI-guided radiation therapy technique using machine learning that may allow for real-time monitoring of glioblastoma treatment response.

Adult survivors of childhood cancer with a high risk of cardiovascular disease may not be receiving proper cardiac testing, according to study findings published in JAMA Network Open.

Younger postmenopausal women who underwent treatment without radiotherapy for early-stage hormone receptor-positive breast cancer experienced low 5-year recurrence rates, according to results presented at San Antonio Breast Cancer Symposium.

SAN ANTONIO — Treatment de-escalation may be possible for patients with breast cancer who respond well to neoadjuvant chemotherapy, according to randomized phase 3 study results presented at San Antonio Breast Cancer Symposium.